{
    "organizations": [],
    "uuid": "e391b53634e5e9fb5a3a21cfd5927fc47c3b71a7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-insys-therapeutics-initiates-phase/brief-insys-therapeutics-initiates-phase-3-clinical-trial-of-cannabidiol-oral-solution-for-treatment-of-infantile-spasms-idUSASB0C8M7",
    "ord_in_thread": 0,
    "title": "BRIEF-Insys Therapeutics Initiates Phase 3 Clinical Trial Of Cannabidiol Oral Solution For Treatment Of Infantile Spasms",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 2, 2018 / 1:49 PM / Updated 10 minutes ago BRIEF-Insys Therapeutics Initiates Phase 3 Clinical Trial Of Cannabidiol Oral Solution For Treatment Of Infantile Spasms Reuters Staff 1 Min Read March 2 (Reuters) - Insys Therapeutics Inc: * INSYS THERAPEUTICS INITIATES PHASE 3 CLINICAL TRIAL OF CANNABIDIOL (CBD) ORAL SOLUTION FOR TREATMENT OF INFANTILE SPASMS Source text for Eikon: Further company coverage:",
    "published": "2018-03-02T15:46:00.000+02:00",
    "crawled": "2018-03-02T16:02:29.024+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "initiate",
        "phase",
        "clinical",
        "trial",
        "cannabidiol",
        "oral",
        "solution",
        "treatment",
        "infantile",
        "spasm",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "insys",
        "therapeutic",
        "inc",
        "insys",
        "therapeutic",
        "initiate",
        "phase",
        "clinical",
        "trial",
        "cannabidiol",
        "cbd",
        "oral",
        "solution",
        "treatment",
        "infantile",
        "spasm",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}